Compounds > erythromycin
Page last updated: 2024-08-21

erythromycin and cilastatin

erythromycin has been researched along with cilastatin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Kocheril, AG; Luttmann, C; Sadaniantz, A1
Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA1
Barthélémy, C; Chai, F; Debaene, B; Décaudin, B; Drouet, M; Lebuffe, G; Odou, P1

Other Studies

6 other study(ies) available for erythromycin and cilastatin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Pneumococcal pericarditis successfully treated with catheter drainage and intravenous antibiotics.
    Catheterization and cardiovascular diagnosis, 1991, Volume: 24, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Cardiac Tamponade; Cilastatin; Cilastatin, Imipenem Drug Combination; Drainage; Drug Combinations; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Infusions, Intravenous; Pericarditis; Pneumococcal Infections

1991
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
    Haematologica, 2002, Volume: 87, Issue:1

    Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin

2002
Endothelial Cell Toxicity of Vancomycin Infusion Combined with Other Antibiotics.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Anti-Bacterial Agents; Cell Death; Cells, Cultured; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Erythromycin; Gentamicins; Human Umbilical Vein Endothelial Cells; Humans; Imipenem; Infusions, Intravenous; Vancomycin

2015